Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Revenue | 39M | 39M | 36M | 38M | 40M | 41M |
| Cost of revenue | 25M | 25M | 24M | 25M | 27M | 26M |
| Gross profit | 14M | 14M | 12M | 13M | 14M | 14M |
| Research and development | 2M | 2M | 2M | 2M | 2M | 1M |
| Selling, general and administrative | 5M | 5M | 5M | 5M | 4M | 5M |
| Operating expenses | 13M | 13M | 12M | 12M | 12M | 13M |
| Operating income | 2M | 1M | −708,000 | 571,000 | 1M | 1M |
| Pre-tax income | 849,000 | 250,000 | −2M | −301,000 | 274,000 | −50,000 |
| Income tax | 196,000 | −128,000 | −454,000 | 75,000 | 34,000 | 261,000 |
| Net income | 653,000 | 378,000 | −1M | −376,000 | 240,000 | −311,000 |
| Earnings per share | 0.09 | 0.05 | −0.16 | −0.05 | 0.03 | −0.04 |
| Earnings per share, diluted | 0.08 | 0.05 | −0.16 | −0.05 | 0.03 | −0.04 |
| Weighted average shares | 8M | 8M | 8M | 8M | 8M | 8M |
| Weighted average shares, diluted | 8M | 8M | 8M | 8M | 8M | 8M |
| Metric | 30/04/2026 | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5M | 4M | 4M | 4M | 5M | 5M | 4M | 5M |
| Receivables | 22M | 19M | 20M |
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 3M | — | — | 4M | — | — |
| Depreciation and amortisation | 1M | — | — | 1M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 19M |
| 21M |
| 21M |
| 25M |
| 23M |
| Inventory | 44M | 43M | 45M | 48M | 51M | 48M | 49M | 51M |
| Current assets | 75M | 71M | 74M | 75M | 81M | 78M | 83M | 83M |
| Property, plant and equipment | 14M | 14M | 15M | 17M | 18M | 16M | 18M | 19M |
| Goodwill | 17M | 17M | 17M | 15M | 15M | 16M | 25M | 25M |
| Total assets | 140M | 138M | 141M | 143M | 150M | 146M | 166M | 169M |
| Current liabilities | 42M | 38M | 41M | 44M | 49M | 46M | 45M | 45M |
| Short-term debt | 4M | 3M | 3M | 6M | 6M | 6M | 6M | 7M |
| Long-term debt | 16M | 18M | 19M | 19M | 20M | 19M | 21M | 23M |
| Total liabilities | 62M | 61M | 64M | 67M | 74M | 70M | 74M | 77M |
| Equity | 78M | 77M | 77M | 76M | 77M | 76M | 92M | 92M |
| Shares outstanding | — | — | 11M | 11M | 12M | 11M | 11M | 11M |
| Shares issued | 11M | 11M | 11M | 11M | 12M | 11M | 11M | 11M |
| Treasury shares | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M |
| — |
| — |
| Share-based compensation | 389,000 | 754,000 | 499,000 | 306,000 | 353,000 | 481,000 |
| Capital expenditure | 36,000 | — | — | 60,000 | — | — |
| Investing cash flow | −36,000 | — | — | −60,000 | — | — |
| Financing cash flow | −2M | — | — | −4M | — | — |